Indivior PLC (INDV) Actualités

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Indivior Announces Q3 2024 Financial Results

Indivior Announces Q3 2024 Financial Results PR Newswire SLOUGH, United Kingdom and RICHMOND, Va., Oct. 24...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Indivior Provides Preliminary Q3 2024 Results; Updates FY 2024 Guidance; Group Continues to Expect SUBLOCADE Peak Net Revenue of >$1.5 Billion

Indivior Provides Preliminary Q3 2024 Results; Updates FY 2024 Guidance; Group Continues to Expect SUBLOCADE...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Indivior's SUBLOCADE® Rapid Induction/Alternative Injection Site Prior Approval Supplement (PAS) Receives FDA Priority Review

Indivior's SUBLOCADE® Rapid Induction/Alternative Injection Site Prior Approval Supplement (PAS) Receives FDA...

Form SC 13D - General Statement of Acquisition of Beneficial Ownership

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]